New York Generics Manufacturer Taken to Task for CGMP Issues

Drug Industry Daily
A A
The FDA warned generic drugmaker RIJ Pharmaceuticals for multiple violations at its Middletown, New York facility, including inadequate water quality.

To View This Article:

Login

Subscribe To Drug Industry Daily